TrialFind
Saved trials
Back to results
Terminated
Phase 2
GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases
NCT03765983
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
View on ClinicalTrials.gov
Official details
GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases — TrialFind